TARDBP and amyotrophic lateral sclerosis: A commercially available ELISA with a biotin-streptavidin method for the detection of TDP-43 has since been used to distinguish a group of FTD patients from a smaller group of ALS patients and C9orf72 repeat expansion carriers of both subgroups [74].